What is Gyre Therapeutics, Inc.'s net debt / EBITDA?

Gyre Therapeutics, Inc. (GYRE) reported net debt / EBITDA of -14.8× in Q1 2026.

How has Gyre Therapeutics, Inc.'s net debt / EBITDA changed year-over-year?

Gyre Therapeutics, Inc.'s net debt / EBITDA decreased by 1223.9% year-over-year, from -1.1× to -14.8×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Gyre Therapeutics, Inc. GYRE Net debt / EBITDA

Net debt / EBITDA at other companies

Eli LillyLLY

1.1×-1.1×

Theravance BiopharmaTBPH

-84.1×—

Rigel PharmaceuticalsRIGL

0.3×+0.2×

Zevra Therapeutics, Inc.ZVRA

-35.8×—

Innoviva, Inc.INVA

-1.8×-2.4×

Royalty PharmaRPRX

5.2×+1.4×

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

net debt/ebitda=-14.8×

Based on the most recent quarter.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s net debt / EBITDA?: Gyre Therapeutics, Inc. (GYRE) reported net debt / EBITDA of -14.8× in Q1 2026.
How has Gyre Therapeutics, Inc.'s net debt / EBITDA changed year-over-year?: Gyre Therapeutics, Inc.'s net debt / EBITDA decreased by 1223.9% year-over-year, from -1.1× to -14.8×.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.